Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Early in the new Netflix miniseries “Apple Cider Vinegar,” the central character of Millie Blake is diagnosed with a rare ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...

NewsNation Anchor Natasha Zouves has much more on the Area 51 veterans fighting for benefits. To watch her full report, tune ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering.

The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

Minnie Driver kicked off her Valentine’s Day festivities a bit early this year with a lovely tribute to her partner Addison O ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

Teddi Mellencamp's estranged husband Edwin Arroyave and their children visited the star shortly before she underwent emergency surgery after doctors found tumors on her brain.

Medicenna's financial statements for the three and nine months ended December 31, 2024, and the related management's discussion and analysis (MD&A) will be available on SEDAR+ at sedarplus.ca.